Paramount–WBD deal faces key EU decision

Paramount’s proposed $110–$111 billion takeover of Warner Bros. Discovery reached a critical stage on June 24, 2026, as company representatives met European Commission officials in Brussels. The discussions focused on remedial commitments that could allow the merger to receive conditional clearance in the European Union. These talks come as the EU emerges as one of the final major regulators assessing the large-scale media consolidation.

The meeting in Brussels forms part of the Commission’s Phase I merger review, during which officials evaluate whether the transaction would significantly harm competition. While details of the discussions have not been publicly disclosed in full, reports indicate that they center on structural and behavioral remedies aimed at addressing competition concerns in film distribution and related markets.

One prominent option under discussion is a requirement for Paramount to exit its joint venture with Universal Pictures, known as United International Pictures. This joint venture currently distributes films in several international markets, and its future role has become a focal point in the regulatory assessment. Requiring an exit from the venture is being examined as a way to reduce concentration and preserve rivalry in film distribution.

The shape and scope of any final remedy package have not yet been finalized. However, the consideration of divesting or restructuring existing distribution arrangements underscores the Commission’s focus on ensuring that the combined company would not gain an undue advantage in key territories. Any commitments offered by Paramount would need to be formally submitted and assessed before clearance can be granted.

The European Commission has set an initial Phase I deadline of July 7, 2026, to either approve the transaction or launch an in-depth Phase II investigation. Reports suggest that the process of lodging formal remedies and evaluating their impact could extend the overall timetable by roughly two weeks into late July. This creates a compressed schedule for Paramount to finalize proposals that satisfy EU concerns.

In addition to the competition review, Brussels is also examining the transaction under the EU’s Foreign Subsidies Regulation. This separate process assesses whether the deal involves unfair foreign funding that could distort the internal market. The subsidy review is running in parallel with the merger assessment, adding another layer of scrutiny before the transaction can move forward within the EU.

Outside Europe, the regulatory process has already advanced, with the U.S. Department of Justice clearing the deal earlier in June 2026. That approval narrows the field of outstanding hurdles and places greater attention on the EU’s forthcoming decision. For investors, the state of EU talks has become a key indicator of the merger’s prospects and timing.

Market reaction reflected this focus on June 24, 2026, when Warner Bros. Discovery shares rose roughly 1.0–1.25% after reports that EU regulators were preparing to approve the takeover conditional on remedies. The share move highlighted investor sensitivity to signals from Brussels as negotiations over commitments continue and the Commission’s July deadline approaches.